A $3.7 billion project in Spalding County called Wallace Jackson Data Center Campus was outlined Tuesday in a state ...

Earlier this month, Apogee Therapeutics reported positive interim Phase 1b data for zumilokibart (APG777) in mild-to-moderate ...

Apogee Therapeutics (APGE) is in focus after releasing interim Phase 1b data for its asthma drug candidate zumilokibart, highlighting robust FeNO biomarker suppression, a clean safety profile, and ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Data quality issues emerge from multiple failure points from development practices to production life cycle, each compounding ...

Instructed Retriever leverages contextual memory for system-level specifications while using retrieval to access the broader ...

For financial institutions, threat modeling must shift away from diagrams focused purely on code to a life cycle view ...

Kathy Hochul approve a major gas pipeline as the culmination of her shift on energy policy. But for skeptics of the climate ...

Ameren trades near 20x forward P/E with the lowest yield, strong CAPEX, data center growth, and regulatory risk priced in.

It's estimated to take several years to secure the land and power to bring a new data center online. Iren has been ahead of ...

The clinical-stage biotech could see its shares plummet should there be any clinical setback.

ProQR Therapeutics N.V. (NASDAQ:PRQR) stock fell 3% Thursday despite the company’s positive announcement of initial data from its Phase 1 trial of AX-0810 and u ...